...in about a third of the cases, cancer disappeared after three to six months...
...The process entails drawing a patient’s blood; extracting the T-cells; inserting a gene that will enable them to identify tumors as targets; then infusing the cancer-killing compound back into the patient at a specialized medical center...
https://www.bloomberg.com/news/articles/2017-07-07/sophie-s-choice-for-oncologists-who-gets-new-life-saving-drug
Novartis...a success rate of 97 percent for the last 30 patients enrolled. The Basel-based drugmaker expects a turnaround of about 22 days at approval time.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment